| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5501673 | PFIZER | Injection cartridge |
Apr, 2013
(11 years ago) | |
| US5716338 | PFIZER | Dual-chamber type injection cartridge with bypass connection |
Feb, 2015
(9 years ago) | |
Caverject Impulse is owned by Pfizer.
Caverject Impulse contains Alprostadil.
Caverject Impulse has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Caverject Impulse are:
- US5501673
- US5716338
Caverject Impulse was authorised for market use on 11 June, 2002.
Caverject Impulse is available in injectable;injection dosage forms.
The generics of Caverject Impulse are possible to be released after 10 February, 2015.
Drugs and Companies using ALPROSTADIL ingredient
Market Authorisation Date: 11 June, 2002
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CAVERJECT IMPULSE family patents
